News

News List
[a:rti]Cure and nSAGE have signed an MOU to jointly develop the next-generation solid tumor treatment CAR-X using each company's platform technology.
Oct, 2024
[a:rti]Cure was selected for the non-clinical trial project of the National New Drug Development Program supported by the government.
May, 2024
[a:rti]Cure was selected for the drug candidate project of the National New Drug Development Program supported by the government.
May, 2022

Search